Fig. 1From: Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in ≥ 50-year-old adultsStudy flow chart (Td, tetanus-diphtheria; PCV13, 13-valent pneumococcal conjugate vaccine)Back to article page